JPRN-UMIN000005820
Completed
Phase 1
Clinical study of Dendritic Cell Vaccine in patients with Gastroenterological Cancer and Hepato-Biliary-Pancreatic Cancer. - Dendritic Cell Vaccine for GI & HBP cancer.
Department of Gastroenterological Surgery, Tokyo Women's Medical University0 sites100 target enrollmentJune 22, 2011
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Esophageal cancer, Stomach cancer, Colon cancer, HCC, ICC, Bile duct cancer, pancreatic cancer
- Sponsor
- Department of Gastroenterological Surgery, Tokyo Women's Medical University
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Pregnancy or lactation 2\.Decision of unsuitableness by principal investigator 3\.Patient with severe underlying disease 4\.Patient with severe allergy disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical study of dendritic cell vaccine combined with transarterial embolization for patients with hepatocellular carcinomaJPRN-UMIN000012702Faculty of Medical Sciences, University of Fukui3
Recruiting
Not Applicable
A pilot study of dendritic cell vaccination for stage IV melanoma following combination lymphodepleting chemotherapy.Stage IV MelanomaCancer - Malignant melanomaACTRN12608000174381niversity of Queensland20
Recruiting
Not Applicable
Clinical trial evaluating dendritic cell vaccination as an adjuvant immunotherapy in patients with pancreatic cancerPancreatic cancerJPRN-UMIN000009994Yokohama City University, Gastroenterological Surgery20
Active, not recruiting
Phase 1
Dendritic cell vaccine immunotherapy in paediatric high grade gliomaPaediatric High grade glioma, excluding brain stem gliomasMedDRA version: 16.1 Level: PT Classification code 10065443 Term: Malignant glioma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-018447-34-GBGreat Ormond Street Hospital for Children NHS Trust20
Withdrawn
Phase 1
Phase I trial of dendritic cell vaccination and celecoxib with postoperative radiotherapy and temozolomide for treatment of malignant glioma.Malignant gliomaCancer - BrainACTRN12609000736246Queensland Institute of Medical Research10